halothane has been researched along with Leukemia, Erythroblastic, Acute in 1 studies
Leukemia, Erythroblastic, Acute: A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Woods, GM | 1 |
| Griffiths, DM | 1 |
1 other study available for halothane and Leukemia, Erythroblastic, Acute
| Article | Year |
|---|---|
Reversible inhibition of natural killer cell activity by volatile anaesthetic agents in vitro.
Topics: Cell Line; Cytotoxicity, Immunologic; Depression, Chemical; Enflurane; Halothane; Killer Cells, Natu | 1986 |